Montagu Acquires Stake in Intech (Orthopaedic Medical Device Manufacturer)
July 12, 2021
Montagu, a European private equity firm, has entered into and closed a strategic investment in Intech, the France-based global leader in contract manufacturing of orthopaedic surgical instruments. The transaction follows negotiations with existing investors Eurazeo PME and Andera Partners and will see Montagu support Intech’s management to accelerate organic and external growth, expand capacity, and strengthen its position in orthopaedics.
- Buyers
- Montagu, Intech management
- Targets
- Intech
- Sellers
- Eurazeo PME, Andera Partners
- Industry
- Medical Devices
- Location
- France
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Warburg Pincus Acquires Integrace Private Limited
July 15, 2026
Pharmaceuticals
Warburg Pincus acquired 100% of Integrace Private Limited, a domestic orthopedics and gynecology-focused pharmaceutical formulations company, leading to full exits for existing shareholders True North Fund VI LLP and Temasek (via V-Science Investments). Industry veteran Rehan Khan was appointed CEO to lead Integrace’s next phase of growth as part of Warburg Pincus’ therapy-focused platform strategy.
-
Montagu and Kohlberg to Acquire Teleflex Medical OEM in a Carve-out Transaction
December 9, 2025
Medical Devices
Montagu and Kohlberg have entered into a definitive agreement to acquire Teleflex Medical OEM from Teleflex Incorporated for $1.5 billion in a carve-out transaction. The business is expected to close in the second half of 2026, subject to regulatory approvals and other customary closing conditions, after which it will operate as an independent global contract developer and manufacturer.
-
Montagu Private Equity Acquires Tyber Medical and Combines It With Intech and Resolve Surgical Technologies
April 8, 2025
Medical Devices
Montagu Private Equity entered into a definitive agreement to acquire Tyber Medical and combine it with its portfolio companies Intech and Resolve Surgical Technologies to create a next-generation orthopedic medical device solutions provider. The closed transaction (announced as closing on 8 April 2025) is designed to deliver integrated, proprietary, market-cleared technologies and development/manufacturing scale for OEM customers across spine, trauma, extremities, and related markets.
-
Montagu to Acquire Johnson Matthey's Medical Device Components Business
March 20, 2024
Medical Devices
Montagu, a London-based private equity firm, has agreed to acquire Johnson Matthey’s carved-out Medical Device Components (MDC) business to create a standalone precision-components platform supporting minimally invasive medical devices. The transaction (reported at approximately US$700 million) will leave MDC led by its existing management and is subject to customary regulatory approvals.
-
Montagu Acquires Majority Stake in HTL Biotechnology
February 28, 2022
Pharmaceuticals
Montagu, a leading private equity firm, has acquired a majority stake in HTL (HTL Biotechnology) from Bridgepoint, with minority shareholders Naxicap and Téthys Invest retaining their holdings. Montagu will support HTL's international expansion, R&D and premium product positioning and has appointed Paul Navarre as Chairman to help drive the company's next growth phase.
-
Montagu Private Equity Acquires RTI Surgical OEM Business
July 20, 2020
Medical Devices
Montagu Private Equity LLP completed the acquisition of the RTI Surgical OEM business (including Tutogen Medical GmbH in related disclosures) from RTI Surgical Holdings, Inc., with the OEM business to operate as a standalone RTI Surgical focused on tissue, biologics and hardware. Montagu will support the business' growth and innovation strategy under President & CEO Olivier Visa following the close in July 2020.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.